Kidney cancer therapies improve prognosis but access remains unequal

Advances in modern therapies are improving kidney cancer prognosis, yet access is uneven, leaving many patients without these treatments. The report highlights a disparity between therapeutic progress and real-world availability, though specific data on the extent of the gap is not provided.